| Dr Rachel Stone Treuting, DO | |
|
7909 S 101st E Ave, Tulsa, OK 74133 | |
| (918) 820-3499 | |
| (918) 820-3502 |
| Full Name | Dr Rachel Stone Treuting |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 15 Years |
| Location | 7909 S 101st E Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396989257 | NPI | - | NPPES |
| 1396989257 | Medicaid | LA | |
| 201131930A | Medicaid | OK |
| Facility Name | Location | Facility Type |
|---|---|---|
| Touro Infirmary | New orleans, LA | Hospital |
| Tulane Medical Center | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crescent City Physicians Inc | 2769370543 | 139 |
News Archive
Scientists at The Scripps Research Institute have new weapons in the fight against HIV. Their new study, published November 17, 2015 as the cover article of the journal Immunity, describes four prototype antibodies that target a specific weak spot on the virus. Guided by these antibodies, the researchers then mimicked the molecular structure of a protein on HIV when designing their own potential HIV vaccine candidate.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
Drinking heavily is disproportionately harmful for the poorest in society, with a greater risk of dying or becoming ill due to alcohol consumption.
› Verified 8 days ago
| Entity Name | Crescent City Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689722340 PECOS PAC ID: 2769370543 Enrollment ID: O20040308001058 |
News Archive
Scientists at The Scripps Research Institute have new weapons in the fight against HIV. Their new study, published November 17, 2015 as the cover article of the journal Immunity, describes four prototype antibodies that target a specific weak spot on the virus. Guided by these antibodies, the researchers then mimicked the molecular structure of a protein on HIV when designing their own potential HIV vaccine candidate.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
Drinking heavily is disproportionately harmful for the poorest in society, with a greater risk of dying or becoming ill due to alcohol consumption.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Stone Treuting, DO 3263 N Delmonico Dr, Fayetteville, AR 72703-3682 Ph: (504) 421-8071 | Dr Rachel Stone Treuting, DO 7909 S 101st E Ave, Tulsa, OK 74133 Ph: (918) 820-3499 |
News Archive
Scientists at The Scripps Research Institute have new weapons in the fight against HIV. Their new study, published November 17, 2015 as the cover article of the journal Immunity, describes four prototype antibodies that target a specific weak spot on the virus. Guided by these antibodies, the researchers then mimicked the molecular structure of a protein on HIV when designing their own potential HIV vaccine candidate.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
Drinking heavily is disproportionately harmful for the poorest in society, with a greater risk of dying or becoming ill due to alcohol consumption.
› Verified 8 days ago
Mr. Anil Kumar Reddy, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9725 East 79th Street, Suit A, Tulsa, OK 74133 Phone: 918-252-0112 Fax: 918-252-0103 | |
Alyxandria Calvert, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4157 S Harvard Ave Ste 101, Tulsa, OK 74135 Phone: 918-949-4390 | |
Abigail Rose Cutter, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2300 E 14th St Ste 104, Tulsa, OK 74104 Phone: 918-982-6800 | |
Kelsey Michelle Harshman, MOT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7031 S Indianapolis Ave, Tulsa, OK 74136 Phone: 918-510-7089 | |
Dr. Bobby N Daniel, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4833 S Sheridan Rd, Suite 414, Tulsa, OK 74145 Phone: 918-488-9992 Fax: 918-488-9993 | |
Carrie Leigh Moss, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1724 S Harvard Ave, Tulsa, OK 74112 Phone: 918-250-7093 Fax: 918-250-9976 | |
Mr. Gregory Scott Argabright, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8303 E 81st St, Suite F, Tulsa, OK 74133 Phone: 918-249-0020 Fax: 918-249-0019 |